ArticleTransplantation and cellular therapy2022

Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.

Anthony C Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.